Skip to content

Healthcare COVID-19 Resources

This page combines all of our communications and resources with regards to COVID-19. If you have any suggestions for this page or unanswered questions, please email dnvclientdropbox@dnv.com.

The module failed to load

Resource Links

 

CMS Coronavirus Waivers & Flexibilities

 

CMS COVID-19 Emergency Declaration Blanket Waivers

May 24, 2021

 

CMS QSO-21-16

Subject: Resuming Hospital Survey Activities Following 30-day Restrictions

 

FDA Ventilator Supply Mitigation

 

FDA Response and Information Regarding COVID-19

 

Secretary Azar COVID-19 Governors Letter

March 24, 2020

 

CMS QSO-20-21-CLIA Combined

Subject: Clinical Laboratory Improvement Amendments (CLIA) Laboratory Guidance During COVID-19 Public Health Emergency

 

CDC Guidance for Universal Source Control

 

ACS Guidance on Resuming Elective Procedures

 

OSHA Response and Information Regarding COVID-19

 

CDC Summary Strategies to Optimize the Supply of PPE during Shortages

 

DNV Healthcare Client Dropbox

Send any questions you have to: dnvclientdropbox@dnv.com

Stay up to date with all of our communications

 

Subscribe to our Email List

Receive emails regarding advisory notices, upcoming events/webinars and our newsletter.

 

Follow DNV on LinkedIn

 

Follow DNV Healthcare on Twitter

 

Connect with our President, Patrick Horine, on LinkedIn

 

Healthcare Advisory Notices

 

Healthcare Customer Communications